Sugiyama Y - Search Results

1

pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes.

Maeda K, Kato Y, Sugiyama Y. Maeda K, et al. Among authors: sugiyama y. J Control Release. 2002 Jul 18;82(1):71-82. doi: 10.1016/s0168-3659(02)00126-8. J Control Release. 2002. PMID: 12106978

2

Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney.

Kusuhara H, Sugiyama Y. Kusuhara H, et al. Among authors: sugiyama y. J Control Release. 2002 Jan 17;78(1-3):43-54. doi: 10.1016/s0168-3659(01)00480-1. J Control Release. 2002. PMID: 11772448

3

Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.

Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, Sugiyama Y. Shitara Y, et al. Among authors: sugiyama d, sugiyama y. Pharm Res. 2002 Feb;19(2):147-53. doi: 10.1023/a:1014264614637. Pharm Res. 2002. PMID: 11883641

4

Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats.

Gotoh Y, Kato Y, Stieger B, Meier PJ, Sugiyama Y. Gotoh Y, et al. Among authors: sugiyama y. Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1245-54. doi: 10.1152/ajpendo.00363.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12006354 Free article.

5

Gender difference in the urinary excretion of organic anions in rats.

Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. Kato Y, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 2002 Aug;302(2):483-9. doi: 10.1124/jpet.102.033878. J Pharmacol Exp Ther. 2002. PMID: 12130705

6

Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.

Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y. Wang DS, et al. Among authors: sugiyama y. J Pharmacol Exp Ther. 2002 Aug;302(2):510-5. doi: 10.1124/jpet.102.034140. J Pharmacol Exp Ther. 2002. PMID: 12130709

7

Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in rats.

Horikawa M, Kato Y, Sugiyama Y. Horikawa M, et al. Among authors: sugiyama y. Pharm Res. 2002 Sep;19(9):1345-53. doi: 10.1023/a:1020358910490. Pharm Res. 2002. PMID: 12403072

8

Mechanism for the tissue distribution of grepafloxacin, a fluoroquinolone antibiotic, in rats.

Suzuki T, Kato Y, Sasabe H, Itose M, Miyamoto G, Sugiyama Y. Suzuki T, et al. Among authors: sugiyama y. Drug Metab Dispos. 2002 Dec;30(12):1393-9. doi: 10.1124/dmd.30.12.1393. Drug Metab Dispos. 2002. PMID: 12433809

9

A novel hepatic-targeting system for therapeutic cytokines that delivers to the hepatic asialoglycoprotein receptor, but avoids receptor-mediated endocytosis.

Sato H, Kato Y, Hayasi E, Tabata T, Suzuki M, Takahara Y, Sugiyama Y. Sato H, et al. Among authors: sugiyama y. Pharm Res. 2002 Nov;19(11):1736-44. doi: 10.1023/a:1020773800358. Pharm Res. 2002. PMID: 12458681

10

Toxicological implications of hepatobiliary transporters.

Kato Y, Suzuki H, Sugiyama Y. Kato Y, et al. Among authors: sugiyama y. Toxicology. 2002 Dec 27;181-182:287-90. doi: 10.1016/s0300-483x(02)00458-4. Toxicology. 2002. PMID: 12505327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,702 results

Search Page

Filters